Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Weatherall

Showing results (81-90 of 363) with videos related to

Pageof 37
Sort By:
The European Respiratory Journal|January 6, 2018
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here?Richard Beasley, Irene Braithwaite, James Fingleton, et al.
Journal of the Royal Society of Medicine|June 2, 2006
Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?Mark Weatherall, Sarah Aldington, Brent Caldwell, et al.
The European Respiratory Journal|November 3, 2018
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severityRichard Beasley, Grace Bird, James Harper, et al.
Current Opinion in Pulmonary Medicine|December 15, 2010
The multiple dimensions of airways disease: targeting treatment to clinical phenotypesPhilippa Shirtcliffe, Mark Weatherall, Justin Travers, et al.
Internal Medicine Journal|February 20, 2019
Cognitive function during exacerbations of chronic obstructive pulmonary diseaseBetty Poot, Justin Travers, Mark Weatherall, et al.
Respirology (Carlton, Vic.)|December 23, 2004
Budesonide once versus twice-daily administration: meta-analysisMatthew Masoli, Mark Weatherall, Shaun Holt, et al.
Respirology (Carlton, Vic.)|August 19, 2006
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthmaSarah Aldington, Mathew Williams, Mark Weatherall, et al.
The European Respiratory Journal|April 6, 2019
Asthma paradoxes: time for a new approach across the spectrum of asthma severityRichard Beasley, Grace Bird, James Harper, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 10, 2010
Long-acting beta-agonists and asthma death: how useful are different study designs to evaluate the potential association?Mark Weatherall, Meme Wijesinghe, Kyle Perrin, et al.
Lancet (London, England)|September 1, 2009
Time to define the disorders of the syndrome of COPDRichard Beasley, Mark Weatherall, Justin Travers, et al.
Pageof 37

Showing results (81-90 of 363) with videos related to

Sort By:
Pageof 37
The European Respiratory Journal|January 6, 2018
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here?Richard Beasley, Irene Braithwaite, James Fingleton, et al.
Journal of the Royal Society of Medicine|June 2, 2006
Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?Mark Weatherall, Sarah Aldington, Brent Caldwell, et al.
The European Respiratory Journal|November 3, 2018
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severityRichard Beasley, Grace Bird, James Harper, et al.
Current Opinion in Pulmonary Medicine|December 15, 2010
The multiple dimensions of airways disease: targeting treatment to clinical phenotypesPhilippa Shirtcliffe, Mark Weatherall, Justin Travers, et al.
Internal Medicine Journal|February 20, 2019
Cognitive function during exacerbations of chronic obstructive pulmonary diseaseBetty Poot, Justin Travers, Mark Weatherall, et al.
Respirology (Carlton, Vic.)|December 23, 2004
Budesonide once versus twice-daily administration: meta-analysisMatthew Masoli, Mark Weatherall, Shaun Holt, et al.
Respirology (Carlton, Vic.)|August 19, 2006
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: a randomized controlled trial in childhood asthmaSarah Aldington, Mathew Williams, Mark Weatherall, et al.
The European Respiratory Journal|April 6, 2019
Asthma paradoxes: time for a new approach across the spectrum of asthma severityRichard Beasley, Grace Bird, James Harper, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 10, 2010
Long-acting beta-agonists and asthma death: how useful are different study designs to evaluate the potential association?Mark Weatherall, Meme Wijesinghe, Kyle Perrin, et al.
Lancet (London, England)|September 1, 2009
Time to define the disorders of the syndrome of COPDRichard Beasley, Mark Weatherall, Justin Travers, et al.
Pageof 37